Skip to Content
Merck
CN
  • Pseudomonas aeruginosa ExoU augments neutrophil transepithelial migration.

Pseudomonas aeruginosa ExoU augments neutrophil transepithelial migration.

PLoS pathogens (2017-08-05)
Michael A Pazos, Bernard B Lanter, Lael M Yonker, Alex D Eaton, Waheed Pirzai, Karsten Gronert, Joseph V Bonventre, Bryan P Hurley
ABSTRACT

Excessive neutrophil infiltration of the lungs is a common contributor to immune-related pathology in many pulmonary disease states. In response to pathogenic infection, airway epithelial cells produce hepoxilin A3 (HXA3), initiating neutrophil transepithelial migration. Migrated neutrophils amplify this recruitment by producing a secondary gradient of leukotriene B4 (LTB4). We sought to determine whether this two-step eicosanoid chemoattractant mechanism could be exploited by the pathogen Pseudomonas aeruginosa. ExoU, a P. aeruginosa cytotoxin, exhibits phospholipase A2 (PLA2) activity in eukaryotic hosts, an enzyme critical for generation of certain eicosanoids. Using in vitro and in vivo models of neutrophil transepithelial migration, we evaluated the impact of ExoU expression on eicosanoid generation and function. We conclude that ExoU, by virtue of its PLA2 activity, augments and compensates for endogenous host neutrophil cPLA2α function, leading to enhanced transepithelial migration. This suggests that ExoU expression in P. aeruginosa can circumvent immune regulation at key signaling checkpoints in the neutrophil, resulting in exacerbated neutrophil recruitment.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Mouse MPO ELISA Kit, for plasma and cell culture supernatant
Sigma-Aldrich
Triton X-100, laboratory grade